Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
EJNMMI Research
|
October 25, 2016
Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour
Handoo Rhee, John Blazak, Chui Ming Tham, et al.
Pathology
|
August 28, 2016
Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced disease
Handoo Rhee, Keng Lim Ng, Brian Wan-Chi Tse, et al.
Ebiomedicine
|
May 29, 2024
TGF-β signalling limits effector function capacity of NK cell anti-tumour immunity in human bladder cancer
Joshua K M Wong, Timothy R McCulloch, Louisa Alim, et al.
Urologic Oncology
|
December 13, 2021
The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison
Arsalan Tariq, Michael Kwok, Adam Pearce, et al.
Urologic Oncology
|
April 25, 2022
Characterization of tumor thrombus in renal cell carcinoma with prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT)
Arsalan Tariq, Stephen McGeorge, Adam Pearce, et al.
European Urology Focus
|
January 9, 2024
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Primary Staging of Selected Renal Tumours: Initial Experience in a Multicentre Cohort
Arsalan Tariq, Adam Pearce, Handoo Rhee, et al.
BMJ Open
|
March 2, 2026
ReFIT study (reversing frailty in transplantation): protocol for a longitudinal study to assess clinical and biomedical changes in frailty through kidney transplantation
Trent Payne, Alyra Shaw, Leila Shafiee Hanjani, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 17, 2023
Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management
Shivanshan Pathmanathan, Arsalan Tariq, Adam Pearce, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
EJNMMI Research
|
October 25, 2016
Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour
Handoo Rhee, John Blazak, Chui Ming Tham, et al.
Pathology
|
August 28, 2016
Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced disease
Handoo Rhee, Keng Lim Ng, Brian Wan-Chi Tse, et al.
Ebiomedicine
|
May 29, 2024
TGF-β signalling limits effector function capacity of NK cell anti-tumour immunity in human bladder cancer
Joshua K M Wong, Timothy R McCulloch, Louisa Alim, et al.
Urologic Oncology
|
December 13, 2021
The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison
Arsalan Tariq, Michael Kwok, Adam Pearce, et al.
Urologic Oncology
|
April 25, 2022
Characterization of tumor thrombus in renal cell carcinoma with prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT)
Arsalan Tariq, Stephen McGeorge, Adam Pearce, et al.
European Urology Focus
|
January 9, 2024
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Primary Staging of Selected Renal Tumours: Initial Experience in a Multicentre Cohort
Arsalan Tariq, Adam Pearce, Handoo Rhee, et al.
BMJ Open
|
March 2, 2026
ReFIT study (reversing frailty in transplantation): protocol for a longitudinal study to assess clinical and biomedical changes in frailty through kidney transplantation
Trent Payne, Alyra Shaw, Leila Shafiee Hanjani, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 17, 2023
Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management
Shivanshan Pathmanathan, Arsalan Tariq, Adam Pearce, et al.
Page
of 4